• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Permeation of cyclophosphamide (NSC-26271) metabolites into tumor cells.

作者信息

Draeger U, Hohorst H J

出版信息

Cancer Treat Rep. 1976 Apr;60(4):423-7.

PMID:1277217
Abstract

The permeation kinetics of cyclophosphamide and its metabolites were studied with Ehrlich ascites tumor cells, murine L1210 leukemia cells, and mouse L929 fibroblasts at 1 degrees C. In contrast to carboxyphosphamide and nor-nitrogen mustard, an equipartition of cyclophosphamide and 4-hydroperoxycyclophosphamide was observed in these cells. First experiments have been done to study the efflux of cyclophosphamide and 4-hydroperoxycyclophosphamide after incubation until saturation with Ehrlich ascites tumor cells. Cyclophosphamide could be washed out completely, whereas, 4-hydroperoxyclophosphamide shows an apparent retention in the cell at 37 degrees C.

摘要

相似文献

1
Permeation of cyclophosphamide (NSC-26271) metabolites into tumor cells.
Cancer Treat Rep. 1976 Apr;60(4):423-7.
2
Biologic activity of two derivatives and six possible metabolites of cyclophosphamide (NSC-26271).环磷酰胺(NSC - 26271)的两种衍生物及六种可能代谢物的生物活性
Cancer Treat Rep. 1976 Apr;60(4):373-9.
3
Synthesis and structure-activity relationships of pre-activated analogs of cyclophosphamide (NSC-26271).环磷酰胺(NSC-26271)预活化类似物的合成及其构效关系
Cancer Treat Rep. 1976 Apr;60(4):381-93.
4
Studies on 4-hydroperoxycyclophosphamide (NSC-181815): a simple preparation method and its application for the synthesis of a new class of "activated" sulfur-containing cyclophosphamide (NSC-26271) derivatives.4-氢过氧环磷酰胺(NSC-181815)的研究:一种简单的制备方法及其在合成新型“活性”含硫环磷酰胺(NSC-26271)衍生物中的应用。
Cancer Treat Rep. 1976 Apr;60(4):429-35.
5
Cyclophosphamide (NSC-26271)-related phosphoramide mustards- recent advances and historical perspective.环磷酰胺(NSC-26271)相关的磷酰胺氮芥——最新进展与历史回顾
Cancer Treat Rep. 1976 Apr;60(4):337-46.
6
Cross-linking of DNA in L1210 cells and nuclei treated with cyclophosphamide and phosphoramide mustard.用环磷酰胺和磷酰胺氮芥处理的L1210细胞及细胞核中DNA的交联作用。
Cancer Treat Rep. 1978 Jan;62(1):23-9.
7
The effect of mechlorethamine and cyclophosphamide on the nicotinamide-adenine dinucleotide glycohydrolase activity in Ehrlich ascites cells and L1210 leukemia cells.氮芥和环磷酰胺对艾氏腹水癌细胞及L1210白血病细胞中烟酰胺腺嘌呤二核苷酸糖水解酶活性的影响。
Proc West Pharmacol Soc. 1965;8:61-3.
8
Different uptake of two alkylating substances by ascites tumor cells.腹水肿瘤细胞对两种烷化剂的摄取差异。
Arzneimittelforschung. 1978;28(11):2150-2.
9
Studies on the selective action of cyclophosphamide (NSC-26271): Inactivation of the hydroxylated metabolite by tissue-soluble enzymes.环磷酰胺(NSC - 26271)的选择性作用研究:组织可溶性酶对羟基化代谢物的失活作用
Cancer Treat Rep. 1976 Apr;60(4):321-6.
10
Identification and pharmacokinetics of cyclophosphamide (NSC-26271) metabolites in vivo.
Cancer Treat Rep. 1976 Apr;60(4):415-22.

引用本文的文献

1
Ifosfamide clinical pharmacokinetics.异环磷酰胺的临床药代动力学。
Clin Pharmacokinet. 1994 Jun;26(6):439-56. doi: 10.2165/00003088-199426060-00003.
2
[Blood level and urinary excretion of activated cyclophosphamide and its deactivation products in man (author's transl)].人体内活化环磷酰胺及其失活产物的血药浓度和尿排泄情况(作者译)
J Cancer Res Clin Oncol. 1980 Jan;96(1):79-92. doi: 10.1007/BF00412899.
3
Comparative study on human pharmacokinetics of activated ifosfamide and cyclophosphamide by a modified fluorometric test.
通过改良荧光测定法对活化异环磷酰胺和环磷酰胺人体药代动力学的比较研究。
J Cancer Res Clin Oncol. 1981;100(1):95-104. doi: 10.1007/BF00405906.
4
Does acrolein contribute to the cytotoxicity of cyclophosphamide?丙烯醛是否对环磷酰胺的细胞毒性有影响?
J Cancer Res Clin Oncol. 1980;98(2):119-26. doi: 10.1007/BF00405956.
5
Macromolecular DNA-damage in murine and human leukemic and lymphoid cells after in vitro exposure to ASTA Z 7557 (INN mafosfamide).体外暴露于ASTA Z 7557(国际非专利药名:马磷酰胺)后小鼠和人类白血病及淋巴细胞中的大分子DNA损伤
Invest New Drugs. 1984;2(2):161-8. doi: 10.1007/BF00232346.
6
Cyclophosphamide-resistant Yoshida ascites tumor cells and their cross resistance to some alkylating agents.环磷酰胺耐药的吉田腹水瘤细胞及其对某些烷化剂的交叉耐药性。
J Cancer Res Clin Oncol. 1979 Jul 27;94(3):257-63. doi: 10.1007/BF00419285.
7
[Permeability of N,N-bis(2-chloroethyl)-diamido-phosphoric-acid into tumor cells (author's transl)].N,N-双(2-氯乙基)-二氨基磷酸对肿瘤细胞的通透性(作者译)
J Cancer Res Clin Oncol. 1979 Feb 19;93(2):161-4. doi: 10.1007/BF00406573.
8
[On the binding of cyclophosphamide and cyclophosphamide-metabolites to serum-albumin (author's transl)].
Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1978 May 31;91(2):127-42. doi: 10.1007/BF00284020.